C1q binding assay for antibody complement activation analysis provides a functional approach to evaluate immune complex interactions and effector potential. Using ELISA or SPR platforms, this assay quantifies the binding strength and kinetics between C1q and biologics such as monoclonal antibodies or Fc-fusion proteins.